Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -8 of 8 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:

Last Modified: 6/1/1992


1.		Phase II Study of 131I-Labeled MOAB CC49 plus IL-1B in Patients with Colorectal Cancer (Summary Last Modified 06/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				NCI				UAC-2110 NCI-T91-0203C, T91-0203

Last Modified: 8/1/1992


2.		Phase II Study of IL-1B in Patients with Metastatic Renal Cell Carcinoma (Summary Last Modified 08/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				WSU-C-98591 NCI-T91-0272D, T91-0272

Last Modified: 3/1/1989


3.		Phase I Study of the Pharmacokinetics, Tolerance to, and Hematologic Effect of Intravenous Interleukin-1-Beta in Adults Receiving 5-Fluorouracil for Advanced Colorectal Cancer (Summary Last Modified 03/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18								MSKCC-88119 NCI-V89-0008

Last Modified: 8/1/1992


4.		Phase I Study of IL-1B/CBDCA/VP-16 in Patients with Metastatic Cancer (Summary Last Modified 08/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				over 18				NCI				SWOG-8940

Last Modified: 6/1/1997


5.		Phase IB Study of Interleukin-1-beta in Patients with Advanced Solid Tumors (Summary Last Modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Supportive care, Treatment				Closed				18 and over				NCI				BRMP-8811A NCI-90-C-62A, NCI-T89-0185N, T89-0185

Last Modified: 5/1/1992


6.		Phase I Study of Concomitant IL-1B and G-CSF Followed by Autologous Stem Cell Rescue from Myeloablative Chemotherapy with ICE (IFF/CBDCA/VP-16) in Patients with Refractory Intermediate-Grade non-Hodgkin's Lymphoma or Hodgkin's Disease (Summary Last Modified 05/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 to physiologic 64				NCI				BRMP-9101D NCI-91-C-99D, NCI-T91-0021N, T91-0021

Last Modified: 2/1/1992


7.		Phase I Study of IL-1B/IL-2 in Patients with Metastatic Kidney Cancer, Colorectal Cancer, or Malignant Melanoma (Summary Last Modified 02/92)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Completed				18 and over								OSU-91HO154 NCI-B91-0021, B91-0021

Last Modified: 1/1/1994


8.		Phase I Pilot Study of IL-1B with and without CBDCA/CTX in Patients with Advanced Cancer (Summary Last Modified 01/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Treatment				Closed				18 and over				NCI				MAYO-900302 NCI-T91-0157C, T91-0157

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute